logo

Veracyte Inc. (VCYT)



Trade VCYT now with
  Date
  Headline
11/2/2019 12:17:02 PM Veracyte Announces New Data That Advance Understanding Of Genomic Alterations For Thyroid Cancer
5/2/2019 9:10:25 PM Veracyte Prices Public Offering Of 5.50 Mln Shares At $23.25/shr
4/22/2019 8:38:17 AM Veracyte Names Alfred Bowie VP, Corporate And Business Development
1/3/2019 7:10:03 AM Veracyte Enters Strategic Collaboration With Johnson & Johnson Innovation In Battle Against Lung Cancer
12/5/2018 7:31:12 AM Veracyte Reports Expansion Of Envisia Genomic Classifier Early Access Program
9/26/2018 8:18:42 AM Veracyte Says Multiple Studies To Be Presented At ATA Meeting
8/31/2018 7:14:30 AM William Blair Reiterates Veracyte Inc. (VCYT) At Outperform
8/29/2018 4:09:58 PM Veracyte Names Angeline McCabe As VP, Investor Relations And Corporate Communications
7/30/2018 1:04:18 PM Veracyte Closes Public Offering Of 5.75 Mln Shares Of Common Stock
7/25/2018 8:31:04 PM Veracyte Prices Underwritten Public Offering Of 5 Mln Shares At $10.25/shr
7/24/2018 4:04:09 PM Veracyte Announces Proposed Public Offering Of Common Stock
7/23/2018 4:08:38 PM Veracyte Q2 Loss/share $0.18 Vs. Loss $0.22 Year Ago
5/1/2018 4:14:10 PM Veracyte Q1 Loss/share $0.27 Vs. Loss $0.24 Year Ago
  
 
>